Respiratory Infection of Cyclophosphamide-Treated Mice with Pseudomonas aeruginosa
- 1 January 1983
- journal article
- research article
- Published by Taylor & Francis in Experimental Lung Research
- Vol. 5 (4) , 305-316
- https://doi.org/10.3109/01902148309061523
Abstract
The dose of cyclophosphamide that permits the colonization of the nasopharynx with P. aeruginosa and the survival of the animal was determined in mice. This dose, 100 mg/kg of cyclophosphamide, allowed P. aeruginosa to colonize but not invade mouse nasal epithelium. Mice treated with 100 mg/kg cyclophosphamide were exposed to aerosol of 35S-labeled P. aeruginosa to study clearance. Results indicated that this dose of cyclophosphamide suppressed both the pulmonary clearance of viable P. aeruginosa (in situ killing) and the clearance of radiolabeled P. aeruginosa (mechanical clearance).This publication has 15 references indexed in Scilit:
- Role of Fibronectin in the Prevention of Adherence of Pseudomonas aeruginosa to Buccal CellsThe Journal of Infectious Diseases, 1981
- Association of Respiratory Tract Colonization with Adherence of Gram-Negative Bacilli to Epithelial CellsThe Journal of Infectious Diseases, 1979
- Pathogenesis of Pseudomonas aeruginosa Pneumonia during ImmunosuppressionThe Journal of Infectious Diseases, 1978
- Pathogenesis of Bacteremia Due to Pseudomonas aeruginosa in Cyclophosphamide-Treated Mice and Potentiation of Virulence of Endogenous StreptococciThe Journal of Infectious Diseases, 1978
- Pseudomonas pneumoniaThe American Journal of Medicine, 1973
- Nosocomial Respiratory Infections with Gram-Negative BacilliAnnals of Internal Medicine, 1972
- Changing Pharyngeal Bacterial Flora of Hospitalized PatientsNew England Journal of Medicine, 1969
- THE ROLE OF THE ALVEOLAR MACROPHAGE IN THE CLEARANCE OF BACTERIA FROM THE LUNGThe Journal of Experimental Medicine, 1964